18.31 USD
↘ 0.27 (1.45%)AT CLOSE (AS OF 07:31 PM EDT)
Vor Biopharma Inc. Common Stock
VORNASDAQ • USD
Market: CLOSED
Shares of Vor Biopharma Inc. Common Stock (VOR) are trading at $18.31. The stock presents a bearish profile across the board: technical indicators signal "Strong Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity and a bullish Golden Cross on the moving averages. Valuation metrics suggest VOR is trading at a discount to its peers, earning an "Attractively Valued" rating.
Technical & fundamental data as of Oct 6, 2026.
Open?$18.85
High?$18.87
Low?$17.97
Prev. Close?$18.58
Volume?472.8K
Avg. Volume?1.1M
VWAP?$18.37
Rel. Volume?0.42x
Bid / Ask
Bid?$15.48 × 100
Ask?$21.43 × 100
Spread?$5.95
Midpoint?$18.46
Valuation & Ratios
Market Cap?1.1B
Shares Out?59.2M
Float?38.7M
Float %?71.4%
P/E Ratio?1.75
P/B Ratio?-5.49
EPS?$10.61
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
Themes
Employees
76
Market Cap
1.1B
Industry
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Website
Listed
2021-02-05
Address
500 BOYLSTON STREET
BOSTON, MA 02116
Phone: 617-655-6580
BOSTON, MA 02116
Phone: 617-655-6580
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-1/3)
Medium-Term (Wave)?▼ Bearish(-3/3)
Short-Term (Ripple)?▼ Bearish(-1/3)
MA Alignment?Mixed
Full Technical Analysis →Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?3
Z-Score?0
Momentum?65
Short Sent.?39
Piotroski F-Score?0/9Weak
Altman Z-Score?-3.09Distress
Confidence?54%Low
Short InterestSqueeze Risk
Short % of Float?20.43%Squeeze Risk
Short Interest?7.9M
Days to Cover?11.1
Free Float38.7M
Avg Daily Volume710.5K
Settlement Date2026-09-15
Financial Health
Current Ratio?19.15Strong
Quick Ratio?19.15Strong
Cash Ratio?4.35Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score100/100
P/E?1.8CHEAP▾
Peers100
S&P97
P/B?-5.49CHEAP▾
S&P97
P/S?N/A▾
P/FCF?N/A▾
EV/EBITDA?-6.7CHEAP▾
S&P97
EV/Sales?N/A▾
Returns & Efficiency
ROE?-313.6%WEAK▾
S&P3
ROA?130.5%STRONG▾
Peers50
S&P97
Cash Flow & Enterprise
FCF?$-140813000
Enterprise Value?$991.4M
Fundamentals ratios updated end of day